Menstrual toxic shock syndrome remains a life-threatening disease, so researchers are exploring safer tampon designs, toxin neutralization, and vaccination.
Clinicians, researchers, and communicators are developing more effective strategies to disseminate information about clinical trials to reach a wider audience. They ultimately expect that this will lead to more inclusive trials.
Clinical trials are one of the most important components of the drug
development process, but they are also one of the most costly, and much of that expense (both money and time) is due to data collection
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.